Psoriasis may up risk of melanoma, hematologic cancer

Psoriasis may up risk of melanoma, hematologic cancer

(HealthDay)—Patients with psoriasis may have a higher risk of melanoma and hematologic cancers than the general population, according to a study published in the April issue of the Journal of the American Academy of Dermatology.

Shivani P. Reddy, from the University of Illinois at Chicago College of Medicine, and colleagues assessed the risk of melanoma and hematologic cancers in patients with psoriasis.

The researchers found that patients with psoriasis had 1.53 times greater risk of developing a malignancy versus patients without psoriasis (P < 0.01). There were no significant differences in risk among patients receiving different treatments (topicals, phototherapy, systemics, or ). For patients who developed malignancy, survival did not differ among those with or without psoriasis.

"Patients with psoriasis may experience an elevated risk of and hematologic cancers, compared with the ," the authors write. "The risk is not increased by systemic or biologic psoriasis therapies."

One author disclosed financial ties to the pharmaceutical industry.

Explore further

Severe psoriasis predominantly affects men

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: Psoriasis may up risk of melanoma, hematologic cancer (2017, March 28) retrieved 18 October 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more